PIC Therapeutics, Inc. is a biopharmaceutical company headquartered in Natick, Massachusetts, dedicated to developing life-changing medicines for patients with cancer. The company focuses on oncology research and therapeutic product development.
Subscribe to see PIC Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PIC Therapeutics, Inc. is a biotechnology company headquartered in Natick, United States. Its most recent funding round raised $6.5M in October 2022. Xcout recorded 1 job posting from PIC Therapeutics, Inc. in the last 90 days.
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6.5M | — | |
| — | $35M | 5 named | |
| SEC Form D filing | $1.7M | — | |
| SEC Form D filing | $11.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 1 job posting from PIC Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see PIC Therapeutics, Inc.'s hiring signals →
A few of PIC Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Go Therapeutics, Inc. is a biopharmaceutical company applying advances in glycoproteomics to develop novel antibody-based cancer therapies and immuno-oncology treatments. Headquartered in Natick, Massachusetts, the company has been active since 2014.
Pi Therapeutics is an Israeli preclinical-stage pharmaceutical company founded in 2015 and based in Ness Ziona. The company focuses on drug discovery and develops novel modulators of protein degradation for the treatment of cancer.
Allorion Therapeutics is a US-based organization headquartered in Natick, Massachusetts, with additional operations in China, specializing in the discovery and creation of small molecule drugs using a science- and data-driven R&D strategy.
Curis, Inc. is a biotechnology company headquartered in Lexington, Massachusetts. The company is engaged in the research and development of drug candidates for the treatment of human cancers.
Accent Therapeutics, Inc. is a biopharmaceutical company headquartered in Lexington, Massachusetts, focused on translating scientific research into novel therapeutics. The company conducts clinical trials, such as Phase 1/2 studies, targeting oncology and other serious diseases.
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about PIC Therapeutics, Inc.? Suggest a correction · Work at PIC Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.